清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Efficacy of photoactivated generation of a meditope-enabled anti-EGFR antibody drug conjugate in RAS/RAF mutant colorectal carcinoma.

作者
Elisabeth M.M. Gardiner,Karin Forster,Calin Dan Dumitru
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (15_suppl): e14059-e14059
标识
DOI:10.1200/jco.2016.34.15_suppl.e14059
摘要

e14059 Background: EGFR is a clinically validated target for advanced colorectal carcinoma, but EGFR targeted therapies are useless against EGFR expressing tumors with K/NRAS mutations. We hypothesized that an anti-EGFR antibody drug conjugate (ADC) that used EGFR to target the tumor and deliver a cytotoxic payload rather than blocking EGFR pathways may be useful for K/NRAS mutant EGFR expressing cancers. To this end, an anti-EGFR ADC was designed using a “meditope-directed” site-specific conjugation strategy. This strategy uses proprietary peptides that bind an antibody Fab fragment noncovalently in a unique site outside the paratope. This novel binding is exploited for site-specific covalent conjugation of cytotoxic payloads to any meditope-enabled antibody. The meditope peptide can be designed with a photoactivatable side chain, allowing the peptide-antibody interaction to be covalent. Herein, we report the development of an anti-EGFR ADC, utilizing a technology which we call SnAP (site-specific novel antibody platform) which may be effective against KRAS/NRAS mutant forms of colorectal carcinoma. Methods: An ADC was designed and tested for cytotoxicity in wild type and KRAS mutant cancer cell lines. Highly efficient site-directed covalent attachment of a toxin to the antibody was facilitated by a novel photoactivatable meditope peptide. Non-GLP safety studies were performed, and conjugation stability was assessed. Efficacy studies were performed in KRAS wildtype as well as KRAS mutant EGFR expressing xenografts. Results: A stable ADC with precisely controlled drug-antibody ratio (DAR) and unaltered affinity for EGFR was created using a novel photoactivation strategy. The meditope-directed ADC showed selective cytotoxic activity in EGFR+ cell lines, irrespective of KRAS mutation status. The potency of the ADC against EGFR dependent tumors was demonstrated in an EGFR expressing colon carcinoma xenograft study. Conclusions: Meditope-directed photoactivation is a novel way to generate site-directed ADCs. Anti-EGFR ADCs created in this fashion may permit patients with KRAS mutated EGFR expressing tumors to receive EGFR targeted therapies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞快的蛋的应助被ay采纳,获得30
2秒前
5秒前
朴素的荧荧完成签到,获得积分10
9秒前
愉快的书桃完成签到,获得积分10
33秒前
加油完成签到 ,获得积分10
44秒前
pigff完成签到,获得积分10
44秒前
系统昵称完成签到,获得积分10
52秒前
白白完成签到,获得积分10
54秒前
黑大侠完成签到 ,获得积分0
1分钟前
如意大神完成签到,获得积分10
1分钟前
武安发布了新的文献求助10
1分钟前
波波波波波6764完成签到 ,获得积分10
1分钟前
欢呼的听枫完成签到,获得积分10
1分钟前
狞风妖完成签到 ,获得积分10
1分钟前
syvshc的应助被科研通管家采纳,获得10
2分钟前
俭朴竺完成签到,获得积分10
2分钟前
超男完成签到 ,获得积分10
2分钟前
丰富凌晴完成签到,获得积分10
2分钟前
Ahui完成签到 ,获得积分10
2分钟前
优雅的梦芝完成签到,获得积分10
2分钟前
温柔的谷冬完成签到,获得积分10
3分钟前
3分钟前
ww发布了新的文献求助10
3分钟前
小伟跑位完成签到,获得积分10
3分钟前
满意的平凡完成签到,获得积分10
3分钟前
奥丁不言语完成签到 ,获得积分10
3分钟前
哈哈哈哈哈完成签到,获得积分10
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
4分钟前
勤奋笙的应助被科研通管家采纳,获得10
4分钟前
幽默绝悟完成签到,获得积分10
4分钟前
北鲲居士完成签到,获得积分10
4分钟前
qianci2009完成签到,获得积分0
4分钟前
甜蜜的紫菜完成签到,获得积分10
4分钟前
舒心的瑾瑜完成签到,获得积分10
4分钟前
失眠紫完成签到,获得积分10
5分钟前
mousfy完成签到 ,获得积分10
5分钟前
5分钟前
YuLu完成签到 ,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185453
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834496
捐赠科研通 7783067
什么是DOI,文献DOI怎么找? 3434570
关于科研通互助平台的介绍 2558912
邀请新用户注册赠送积分活动 2481326